| Autor: |
Marchlinski Francis E, Jessup Mariell L, Hsia Henry H |
| Jazyk: |
angličtina |
| Rok vydání: |
2000 |
| Předmět: |
|
| Zdroj: |
Current Controlled Trials in Cardiovascular Medicine, Vol 1, Iss 2, Pp 98-101 (2000) |
| Druh dokumentu: |
article |
| ISSN: |
1468-6708 |
| DOI: |
10.1186/cvm-1-2-098 |
| Popis: |
Abstract Sudden death is a major cause of mortality in patients with ventricular dysfunction. The highest risk occurs among patients with less severe functional impairment. Current methods of risk stratification are inadequate, and a rational therapy for prevention of sudden death is not available. The implantable cardioverter-defibrillator (ICD) has proven to be more effective than drugs in reducing sudden-death risk in some subsets of patients. Empiric ICD therapy, targeting the general population with mild to moderate heart failure, will maximize the impact of such a strategy to prevent sudden death and improve long-term survival. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
